German Personal Products Stock News

On 24 April 2026, Humacyte, Inc. announced it had amended its distribution agreement with Fresenius Medical Care, realigning ex‑U.S. rights to Symvess, an acellular tissue engineered vessel that remains investigational outside its FDA‑approved extremity vascular trauma use. This reshaped collaboration highlights Fresenius Medical Care’s evolving approach to vascular access and regenerative medicine, potentially influencing how it prioritizes future international therapy offerings. We’ll now...

Why Aumovio Stock Is Drawing Attention Now Aumovio (XTRA:AMV0) is back on investor radar after recent trading leaves the stock down for the year but slightly higher over the past month, prompting fresh questions about its valuation and business mix. See our latest analysis for Aumovio. Recent trading has been choppy, with a 1-day share price return decline of 2.04% and a 7-day share price return decline of 3.99%, set against a 30-day share price return of 3.80% that partly offsets the 19.02%...

Hannover Rück SE ( ETR:HNR1 ) is about to trade ex-dividend in the next couple of days. The ex-dividend date is usually...

In late April 2026, Deutsche Bank reported record first-quarter results, with net interest income of €4,204 million and net income of €2,118 million, while also issuing a broad suite of senior, unsecured Eurobond and Eurodollar notes across fixed, variable, and zero-coupon structures. An especially material development was the private banking arm’s profit before tax rising 39% and assets under management increasing 10% year-on-year, underpinned by strong net inflows that highlight robust...

As European markets navigate a complex landscape marked by stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index has remained relatively stable with modest gains. In this environment, dividend stocks can offer a degree of stability and income potential for investors seeking to balance risk amid economic uncertainties.

In late April 2026, Delivery Hero introduced Herogen, an in-house autonomous AI software delivery agent that can independently write, test, and propose production code, already handling over 100 code change requests per day and saving an estimated 250,000 hours of manual coding annually. By shifting developers’ work from writing code to directing AI through natural language, Herogen is repositioning engineering roles toward higher-level software architecture and potentially reshaping how...

If you are wondering whether DWS Group GmbH KGaA is fairly priced right now, the key question is whether the current share price lines up with its underlying value. The stock last closed at €59.00, with returns of 3.5% over 7 days, 6.5% over 30 days, 4.6% year to date and 30.3% over 1 year, alongside a very large 3 year return and 135.5% over 5 years. Recent coverage has focused on DWS Group GmbH KGaA as an asset manager, which can affect how investors think about its fee resilience, cost...

If you are wondering whether flatexDEGIRO's share price still offers value at current levels, the key question is how its market price compares with its underlying fundamentals. The stock recently closed at €30.48, with returns of 0.2% over 7 days, 1.4% over 30 days, a 16.0% decline year to date, and 29.2% over the last year. Together, these figures give mixed signals about how the market is pricing its prospects and risks. Recent coverage has focused on flatexDEGIRO's position within online...

While Clearway Energy, Inc. ( FRA:NY4B ) might not have the largest market cap around , it saw a significant share...

Wacker Chemie (XTRA:WCH) has caught investor attention after reporting Q1 EBITDA of €173 million, a 45% year-over-year increase, supported by its PACE cost program and upgraded full-year 2026 sales expectations. See our latest analysis for Wacker Chemie. Wacker Chemie’s share price has moved to €93.65, with a 30-day share price return of 14.14% and a 90-day return of 35.53%. The 1-year total shareholder return of 44.43% contrasts with weaker 3 and 5-year total returns, suggesting momentum has...

adidas AG ( ETR:ADS ) is about to trade ex-dividend in the next four days. The ex-dividend date is commonly two...

Wondering if Rheinmetall at €1,355.80 is pricing in too much optimism or leaving room on the table for value focused investors like you? The stock is up 2.8% over the last week, but shows a 13.7% decline over 30 days, a 15.4% decline year to date, and a 13.5% decline over the past year, all following a very large 3 year gain and an even larger 5 year gain. Recent coverage has focused on Rheinmetall's position in defense and capital goods, which often draws attention whenever sector sentiment...

BASF (XTRA:BAS) has just opened 2026 with Q1 numbers that cap a year where trailing twelve month revenue sat at about €59.7b and basic EPS came in at €1.61. Over recent quarters, the company has seen revenue move from €17.6b and EPS of €1.53 in Q1 2024 to €14.0b and EPS of €0.57 in Q4 2025, with trailing net income from continuing operations at €1.43b across the last reported twelve months. With net profit margins over the past year at 2.4% and earnings growth of 26.6% supported by forecasts...

Investors may be wondering whether Deutsche Telekom's share price reflects its true worth, or if the market is mispricing this telecom heavyweight right now. The stock last closed at €27.57, with a 10.4% decline over 30 days and a 10.3% decline over 1 year, despite longer term returns of 41.7% over 3 years and 96.4% over 5 years, which hint at a very different picture. Recent headlines have focused on Deutsche Telekom's position within the European telecom sector, including its role in...

It looks like Daimler Truck Holding AG ( ETR:DTG ) is about to go ex-dividend in the next 4 days. The ex-dividend date...

adidas AG ( ETR:ADS ) just released its latest first-quarter results and things are looking bullish. Results were good...

Merck KGaA (XTRA:MRK) announced a collaboration with Remepy to develop Hybrid Drugs that pair pharmaceuticals with app-based digital therapeutics for rare and difficult-to-treat cancers. The company also introduced its first bio-based solvent portfolio for high-performance liquid chromatography, aimed at supporting more sustainable laboratory operations. For you as an investor, these moves highlight how Merck KGaA is leaning into two active themes in healthcare: digital therapeutics and...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see BASF SE...

PUMA (XTRA:PUM) has just posted its Q1 2026 scorecard, and investors are coming off a volatile 2025 where quarterly revenue moved from €2.08b in Q1 to €1.56b in Q4 while EPS swung from a small profit of essentially €0.00 in Q1 to a loss of €2.28 per share in Q4. Over the same stretch, net income shifted from a €0.5m profit in Q1 2025 to a €336.3m loss by Q4 as revenue stepped down from €2.31b in Q3 2024 to €1.56b in Q4 2025, which puts the spotlight firmly on how much of each euro of sales is...

If you are wondering whether Allianz is fairly priced or has more room to run, an effective starting point is to look closely at what the current share price implies about its value. The stock recently closed at €389.00, with returns of 8.3% over 30 days, 11.4% over 1 year and 123.1% over 5 years. These figures can influence how much risk and upside investors feel is still on the table. Recent coverage around Allianz has focused on its position as a large European insurer, its capital...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see SAP SE...

Readers hoping to buy Deutsche Post AG ( ETR:DHL ) for its dividend will need to make their move shortly, as the stock...

Deutsche Bank (XTRA:DBK) has opened Q1 2026 earnings season with context set by Q4 2025 figures of €6.7b in revenue, basic EPS of €0.21 and net income of €416m, alongside a trailing twelve month EPS of €2.99 on revenue of €29.7b and net income of €5.8b. Over the past few quarters, revenue has ranged from €7.0b to €7.8b, while quarterly basic EPS moved between €0.21 and €1.00 and net income between €416m and €1.97b. This gives investors a clearer view of how profitability is tracking into the...

Nagarro (XTRA:NA9) has put fresh numbers on the table for FY 2025, with Q3 revenue of €254.6 million and basic EPS of €1.69, while trailing 12 month revenue stands at about €1.0 billion and EPS at €3.76. Over recent quarters, revenue has moved from €244.2 million in Q2 2024 to €252.0 million in Q2 2025, and from €246.7 million in Q4 2024 to €254.6 million in Q3 2025. EPS shifted from €0.90 and €0.59 in those 2024 quarters to €0.65 and €1.69 in the latest 2025 prints. For you as an investor,...